Summary
Elevance Health, Inc. (formerly Anthem, Inc.) held its Annual Meeting of Shareholders on May 18, 2022, where key corporate governance matters were decided. The most significant outcome for investors is the approval of the company's name change to Elevance Health, Inc., reflecting a broader strategic direction beyond its historical focus. This change was overwhelmingly supported by shareholders, signaling a positive reception to the company's evolution. Furthermore, the election of directors for three-year terms and the ratification of Ernst & Young LLP as the independent auditor both received strong shareholder backing, underscoring confidence in the company's leadership and financial oversight. While the advisory vote on executive compensation was also approved, and proposals related to political funding and racial impact audits were not passed, the overall results indicate a stable and supportive shareholder base for the company's strategic initiatives and established governance practices.
Key Highlights
- 1Shareholder approval for the company's name change from Anthem, Inc. to Elevance Health, Inc.
- 2All nominated directors were elected to serve three-year terms expiring in 2025.
- 3The appointment of Ernst & Young LLP as the independent registered public accounting firm for 2022 was ratified.
- 4Shareholders approved the company's executive compensation in an advisory vote.
- 5A shareholder proposal to prohibit political funding was not approved.
- 6A shareholder proposal requesting a racial impact audit and report was not approved.
- 7The meeting confirmed strong shareholder confidence in the company's board and financial reporting.